Rentokil Initial Regulatory News (RTO)

28 April 2025

RENTOKIL INITIAL PLC

BENCHMARK USD ISSUANCE OF $750 MILLION 5.000% NOTES DUE 2030 AND$500 MILLION 5.625% NOTES DUE 2035

On 28 April 2025, Rentokil Terminix Funding, LLC, a wholly-owned finance subsidiary of Rentokil Initial plc (the "Company"), issued its inaugural senior, unsecured $750 million 5.000% Notes due 2030 and $500 million 5.625% Notes due 2035 (together, the "Notes") guaranteed by the Company and offered in the United States only to qualified institutional buyers pursuant to Rule 144A under the U.S. Securities Act of 1933, as amended (the "Securities Act") and outside the United States pursuant to Regulation S under the Securities Act. The Company intends to use approximately $700 million of the net proceeds from the Notes issuance to repay a term loan which otherwise matures in October 2025, and otherwise for general corporate purposes.

Application has been made to list the Notes on the Official List of the Irish Stock Exchange plc trading as Euronext Dublin ("Euronext Dublin") and to trade the Notes on the Global Exchange Market of Euronext Dublin.

Enquiries:

Investors / Analysts: Peter Russell, Rentokil Initial plc, + 44 7795 166506

Media: Malcolm Padley, Rentokil Initial plc, +44 7788 978199

DISCLAIMER

The information contained herein shall not constitute or form part of any offer to sell or solicitation of an offer to buy the securities referred to herein. The Notes have not been and will not be registered under the Securities Act, or any state securities laws and, unless so registered, may not be offered or sold within the United States or to, or for the account or the benefit of, US persons, as defined in Regulation S under the Securities Act, except pursuant to an exemption from or in a transaction not subject to the registration requirements of the Securities Act and in compliance with any applicable state securities laws.